Use this medication on the skin only. Do not use it on the face, groin, or underarms unless directed to do so by your doctor. Wash and dry your hands before using. Clean and dry the affected area.

Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of ...

Clobetasol propionate 0.05%; crm; oint; gel; soln for scalp application. Treat infection if present; discontinue if infection persists or worsens. Do not use near eyes, or on diaper dermatitis or ...

Clobetasol propionate 0.05%. Treat infection if present; discontinue if infection persists or worsens. Avoid contact with eyes, or on diaper dermatitis or pre-existing skin atrophy. Do not use ...

Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market clobetasol ...

Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain ...

Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain ...

This partnership aims to enhance ophthalmic care by providing better treatment for post-operative inflammation and pain in patients across 11 countries. APP13007 is a novel, patent protected and ...

Drug maker Cipla on Tuesday said it has inked an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the commercialisation of clobetasol propionate ophthalmic suspension. As ...

Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market clobetasol propionate ophthalmic suspension 0.05% (APP13007) across 11 countries ...